tradingkey.logo
tradingkey.logo
Search

Outlook Therapeutics Inc

OTLK
Add to Watchlist
1.305USD
-0.035-2.61%
Close 07-23 16:00ETQuotes delayed by 15 min
136.52MMarket Cap
LossP/E TTM

OTLK Financials

See Outlook Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Outlook Therapeutics Inc Earnings Date

Latest Release
May 15, 2026
EPS / Forecast
-0.05/-0.12
Revenue / Forecast
127.44K/4.40M
Period
FY2025 Earnings
Revenue(YoY)
1.41M
--
EPS(YoY)
-1.79
55.85%
Analyst Rating
BUY
2026/07/23
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
96.38%-0.05
-153.41%-0.38
-217.43%-0.28
-128.52%-0.55
81.25%-1.50
183.48%0.72
124.01%0.24
218.78%1.91
-1444.33%-8.01
47.67%-0.86
---1.00
---1.61
---0.52
---1.64
---6.23
----
----
----
----
----
Revenue
--127.44K
---1.21M
----
--1.51M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net Profit
90.39%-4.45M
-232.69%-23.06M
-333.56%-13.29M
-145.38%-20.15M
59.44%-46.36M
255.46%17.38M
143.81%5.69M
314.80%44.41M
-1617.52%-114.29M
40.10%-11.18M
9.44%-12.99M
-17.87%-20.68M
66.23%-6.65M
-29.04%-18.66M
-7.02%-14.35M
-43.81%-17.54M
-50.34%-19.70M
-0.05%-14.46M
-35.10%-13.40M
-304.55%-12.20M
Net Margin
---3494.28%
----
----
---1338.75%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Gross Margin
---17.18%
----
----
--70.78%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Debt to assets ratio
-28.89%123.19%
11.18%201.00%
57.77%161.14%
123.31%153.79%
128.54%173.24%
7.27%180.78%
-7.21%102.14%
-11.89%68.87%
28.64%75.80%
231.88%168.53%
--110.08%
--78.16%
--58.92%
--50.78%
--38.32%
----
----
----
----
----
Revenue
--127.44K
---1.21M
----
--1.51M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating profit
-13.20%-14.03M
37.59%-13.48M
24.32%-17.31M
19.50%-15.75M
34.57%-12.39M
-109.31%-21.61M
-83.62%-22.88M
-7.83%-19.56M
-176.98%-18.94M
34.20%-10.32M
10.93%-12.46M
-6.56%-18.14M
63.84%-6.84M
-19.30%-15.69M
-4.11%-13.99M
-48.36%-17.02M
-49.78%-18.91M
7.34%-13.15M
-34.17%-13.44M
2.55%-11.47M
Net Profit
90.39%-4.45M
-232.69%-23.06M
-333.56%-13.29M
-145.38%-20.15M
59.44%-46.36M
255.46%17.38M
143.81%5.69M
314.80%44.41M
-1617.52%-114.29M
40.10%-11.18M
9.44%-12.99M
-17.87%-20.68M
66.23%-6.65M
-29.04%-18.66M
-7.02%-14.35M
-43.81%-17.54M
-50.34%-19.70M
-0.05%-14.46M
-35.10%-13.40M
-304.55%-12.20M
Current assets
17.40%20.90M
9.57%17.17M
-36.57%17.39M
-53.75%21.10M
-69.18%17.81M
-23.16%15.67M
-11.50%27.42M
6.04%45.62M
8.92%57.79M
-66.94%20.39M
12.57%30.98M
14.67%43.02M
-20.28%53.05M
-20.38%61.68M
27.95%27.52M
17.61%37.51M
51.96%66.55M
602.25%77.47M
19.86%21.51M
12.97%31.90M
Total current liabilities
56.65%38.88M
1.70%49.06M
7.66%45.81M
-26.00%31.49M
-54.10%24.82M
4.93%48.24M
-8.94%42.55M
-14.77%42.55M
24.24%54.08M
204.80%45.97M
136.86%46.73M
170.92%49.93M
38.57%43.53M
-24.40%15.08M
192.20%19.73M
-6.15%18.43M
31.44%31.41M
64.55%19.95M
-57.50%6.75M
6.42%19.64M
Total assets
14.77%21.89M
7.25%18.24M
-35.52%18.58M
-52.45%22.39M
-67.68%19.08M
-21.58%17.01M
-10.77%28.82M
5.95%47.09M
9.26%59.03M
-65.41%21.68M
13.23%32.30M
15.18%44.45M
-20.18%54.02M
-20.32%62.69M
25.06%28.53M
17.35%38.59M
50.04%67.69M
528.52%78.68M
15.60%22.81M
8.73%32.88M
Total liabilities
-1.26%50.89M
-15.62%56.79M
-50.17%50.77M
-54.44%59.58M
-73.33%51.54M
46.21%67.30M
118.02%101.90M
161.79%130.77M
343.92%193.26M
-1.92%46.03M
136.16%46.74M
169.92%49.95M
37.24%43.54M
57.19%46.93M
8.72%19.79M
-8.08%18.51M
29.69%31.72M
29.84%29.85M
7.68%18.20M
4.44%20.13M
Total equity
10.68%-28.99M
23.35%-38.55M
55.95%-32.19M
55.55%-37.19M
75.82%-32.46M
-106.59%-50.29M
-406.15%-73.08M
-1420.55%-83.67M
-1379.94%-134.24M
-254.48%-24.34M
-265.26%-14.44M
-127.40%-5.50M
-70.84%10.49M
-67.72%15.76M
89.62%8.74M
57.52%20.08M
74.14%35.96M
566.10%48.82M
63.02%4.61M
16.27%12.75M
Net operating income
52.80%-7.83M
-36.21%-14.94M
27.12%-12.38M
39.01%-11.90M
13.93%-16.58M
15.84%-10.97M
-33.28%-16.98M
-47.64%-19.51M
-137.44%-19.27M
-46.41%-13.03M
-24.30%-12.74M
37.36%-13.22M
43.39%-8.11M
19.01%-8.90M
-14.02%-10.25M
-4.49%-21.10M
-22.03%-14.33M
17.52%-10.99M
25.56%-8.99M
-239.05%-20.19M
Net investment
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
----
Net financing
-62.58%6.90M
791.51%15.53M
10155.73%11.56M
207.49%13.25M
-67.16%18.44M
54839.96%1.74M
-104.74%-114.95K
30.69%4.31M
9501.66%56.14M
-100.01%-3.18K
49.08%2.42M
129.16%3.30M
-122.90%-597.13K
-34.23%43.85M
-56.93%1.63M
-516.26%-11.30M
-93.98%2.61M
948.65%66.66M
471.37%3.78M
-89.62%2.72M

FAQs

What is the total revenue of Outlook Therapeutics Inc?

According to Outlook Therapeutics Inc's FY2025 earnings report, its total revenue reached 1.41M, with a year-on-year change of 1.41M.

What are the current assets of Outlook Therapeutics Inc?

According to Outlook Therapeutics Inc's FY2025 earnings report, its current assets were 17.39M, with a year-on-year change of -36.57.

What are the total assets of Outlook Therapeutics Inc?

According to Outlook Therapeutics Inc's FY2025 earnings report, its total assets of Outlook Therapeutics Inc were 18.58M, with a year-on-year change of -35.52.

What are the total liabilities of Outlook Therapeutics Inc?

According to Outlook Therapeutics Inc's FY2025 earnings report, its total liabilities of Outlook Therapeutics Inc were 50.77M, with a year-on-year change of -50.17.

What is the total equity of Outlook Therapeutics Inc?

According to Outlook Therapeutics Inc's FY2025 earnings report, its total equity of Outlook Therapeutics Inc was -32.19M, with a year-on-year change of 55.95.

What is the net operating income of Outlook Therapeutics Inc?

According to Outlook Therapeutics Inc's FY2025 earnings report, its net operating income of Outlook Therapeutics Inc was -67.06M, with a year-on-year change of 6.47.

What is the net financing of Outlook Therapeutics Inc?

According to Outlook Therapeutics Inc's FY2025 earnings report, its net financing of Outlook Therapeutics Inc was 44.98M, with a year-on-year change of -25.43.

What is the Earnings Per Share (EPS) of Outlook Therapeutics Inc?

According to Outlook Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.79, with a year-on-year change of 55.85.

What is the net income of Outlook Therapeutics Inc?

According to Outlook Therapeutics Inc's FY2025 earnings report, its net income was -62.42M, with a year-on-year change of 17.17.

What is the debt-to-asset ratio of Outlook Therapeutics Inc?

According to Outlook Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 161.14, with a year-on-year change of 57.77.

What is the Return on Assets (ROA) of Outlook Therapeutics Inc?

According to Outlook Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -263.36, with a year-on-year change of -6.79.

What is the operating profit of Outlook Therapeutics Inc?

According to Outlook Therapeutics Inc's FY2025 earnings report, its operating profit was -67.06M, with a year-on-year change of 6.47.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.